HK-Macau Drug & Device Access Scheme

Service Introduction

Hong Kong-Macau Drug and Device Connect

The "Hong Kong-Macau Drug and Device Connect" policy refers to the use of clinically urgently needed drugs already marketed in Hong Kong and Macau, as well as clinically urgently needed medical devices with advanced clinical applications that have been procured and used by public hospitals in Hong Kong and Macau, within designated medical institutions in the Guangdong-Hong Kong-Macao Greater Bay Area. In December 2025, Heyou Pinnacle Medical Center was officially designated as one of the fourth

Heyou Pinnacle Medical Center is committed to a multidisciplinary approach. When needed, we assemble specialists for a comprehensive case review, delivering truly integrated, one-stop care.

Book Now

Approved Drugs and Medical Devices

Approved Drugs and Devices

Through the "Hong Kong-Macau Drug and Device Connect" initiative, approvals for 7 types of drugs and consumables have been obtained to date, covering multiple specialties including Rheumatology and Immunology, Neurology, Ophthalmology, and Otorhinolaryngology, with 3 additional drugs being progressively introduced.

- Otolaryngology (Cochlear Implant)
  
  Provides an optimal auditory reconstruction solution for patients with severe hearing loss.
- Joint and Sports Medicine (Cartilage Regeneration Collagen Scaffold)
  
  Imported from Germany, injected via arthroscopic minimally invasive procedure to promote hyaline cartilage regeneration. Suitable for cartilage defects in the knee, hip, shoulder, and wrist joints, avoiding secondary surgery for tissue harvesting.
- Neurology (Eptinezumab)
  
  For preventive treatment of adult migraine, administered once every 3 months, significantly reducing the frequency and duration of migraine attacks.
- Rheumatology and Immunology (Canakinumab)
  
  For autoinflammatory diseases unresponsive to conventional drugs and frequent acute gout attacks, it blocks inflammation at the source, offering new hope for patients with poor response to traditional treatments.
- Otolaryngology (Cochlear Implant)
  
  Provides an optimal auditory reconstruction solution for patients with severe hearing loss.
- Joint and Sports Medicine (Cartilage Regeneration Collagen Filler Scaffold)
  
  Imported from Germany, injected via arthroscopic minimally invasive procedure to promote hyaline cartilage regeneration. Suitable for cartilage injuries of the knee, hip, shoulder, and wrist joints, avoiding secondary surgery for tissue harvesting.
- Neurology (Eptinezumab)
  
  Indicated for the preventive treatment of migraine in adults. Administered once every 3 months, it can significantly reduce the frequency and duration of migraine attacks.
- Rheumatology and Immunology (Canakinumab)
  
  Targets autoinflammatory diseases refractory to conventional therapy and frequent acute gout attacks, blocking inflammation at the source and offering new hope for patients with poor response to standard treatments.
- Otolaryngology (Cochlear Implant)
  
  Provides an optimal auditory reconstruction solution for patients with severe hearing loss.
- Joint and Sports Medicine (Cartilage Regeneration Collagen Filler Scaffold)
  
  Imported from Germany, injected via arthroscopic minimally invasive procedure to promote hyaline cartilage regeneration. Suitable for cartilage injuries of the knee, hip, shoulder, and wrist joints, avoiding secondary surgery for tissue harvesting.
- Neurology (Eptinezumab)
  
  For preventive treatment of migraine in adults, administered once every 3 months, significantly reducing the frequency and number of migraine days.
- Rheumatology and Immunology (Canakinumab)
  
  For autoinflammatory diseases refractory to conventional therapies and frequent acute gout attacks, it blocks inflammation at the source, offering new hope for patients with poor response to traditional treatments.
- Otolaryngology (Cochlear Implant)
  
  Providing a superior auditory rehabilitation solution for patients with severe hearing loss.
- Joint and Sports Medicine (Cartilage Regeneration Collagen Scaffold)
  
  Imported from Germany, injected via arthroscopic minimally invasive procedure to promote hyaline cartilage regeneration. Suitable for cartilage defects in the knee, hip, shoulder, and wrist joints, avoiding secondary surgery for tissue harvesting.
- Neurology (Eptinezumab)
  
  For preventive treatment of migraine in adults, administered once every 3 months, significantly reducing the frequency and number of migraine days.
- Rheumatology and Immunology (Canakinumab)
  
  For autoinflammatory diseases refractory to conventional therapies and frequent acute gout attacks, it blocks inflammation at the source, offering new hope for patients with poor response to traditional treatments.

Otolaryngology (Cochlear Implant)

Provides an optimal auditory reconstruction solution for patients with severe hearing loss.
Joint and Sports Medicine (Cartilage Regeneration Collagen Scaffold)

Imported from Germany, injected via arthroscopic minimally invasive procedure to promote hyaline cartilage regeneration. Suitable for cartilage defects in the knee, hip, shoulder, and wrist joints, avoiding secondary surgery for tissue harvesting.
Neurology (Eptinezumab)

For preventive treatment of adult migraine, administered once every 3 months, significantly reducing the frequency and duration of migraine attacks.
Rheumatology and Immunology (Canakinumab)

For autoinflammatory diseases unresponsive to conventional drugs and frequent acute gout attacks, it blocks inflammation at the source, offering new hope for patients with poor response to traditional treatments.
Otolaryngology (Cochlear Implant)

Provides an optimal auditory reconstruction solution for patients with severe hearing loss.
Joint and Sports Medicine (Cartilage Regeneration Collagen Filler Scaffold)

Imported from Germany, injected via arthroscopic minimally invasive procedure to promote hyaline cartilage regeneration. Suitable for cartilage injuries of the knee, hip, shoulder, and wrist joints, avoiding secondary surgery for tissue harvesting.
Neurology (Eptinezumab)

Indicated for the preventive treatment of migraine in adults. Administered once every 3 months, it can significantly reduce the frequency and duration of migraine attacks.
Rheumatology and Immunology (Canakinumab)

Targets autoinflammatory diseases refractory to conventional therapy and frequent acute gout attacks, blocking inflammation at the source and offering new hope for patients with poor response to standard treatments.
Otolaryngology (Cochlear Implant)

Provides an optimal auditory reconstruction solution for patients with severe hearing loss.
Joint and Sports Medicine (Cartilage Regeneration Collagen Filler Scaffold)

Imported from Germany, injected via arthroscopic minimally invasive procedure to promote hyaline cartilage regeneration. Suitable for cartilage injuries of the knee, hip, shoulder, and wrist joints, avoiding secondary surgery for tissue harvesting.
Neurology (Eptinezumab)

For preventive treatment of migraine in adults, administered once every 3 months, significantly reducing the frequency and number of migraine days.
Rheumatology and Immunology (Canakinumab)

For autoinflammatory diseases refractory to conventional therapies and frequent acute gout attacks, it blocks inflammation at the source, offering new hope for patients with poor response to traditional treatments.
Otolaryngology (Cochlear Implant)

Providing a superior auditory rehabilitation solution for patients with severe hearing loss.
Joint and Sports Medicine (Cartilage Regeneration Collagen Scaffold)

Imported from Germany, injected via arthroscopic minimally invasive procedure to promote hyaline cartilage regeneration. Suitable for cartilage defects in the knee, hip, shoulder, and wrist joints, avoiding secondary surgery for tissue harvesting.
Neurology (Eptinezumab)

For preventive treatment of migraine in adults, administered once every 3 months, significantly reducing the frequency and number of migraine days.
Rheumatology and Immunology (Canakinumab)

For autoinflammatory diseases refractory to conventional therapies and frequent acute gout attacks, it blocks inflammation at the source, offering new hope for patients with poor response to traditional treatments.

Standardized Medication Management

Standardized Medication Management

Introducing new drugs is only the first step; standardized use is the key. Heyou Pinnacle Medical Center has established multidisciplinary treatment teams that strictly adhere to international guidelines to develop individualized plans for each patient. A comprehensive management system encompassing medication evaluation, efficacy tracking, and adverse reaction monitoring has been implemented. This ensures patients not only have access to these therapies but can also use them with confidence.

Heyou Pinnacle Medical Center is committed to a multidisciplinary approach. When needed, we assemble specialists for a comprehensive case review, delivering truly integrated, one-stop care.
Leading-Edge Medical Treatment Base

Leading-Edge Medical Treatment Base

With the introduction of international drugs and devices, Heyou Pinnacle Medical Center is progressively becoming a leading-edge window for advanced international therapies in the Greater Bay Area. Moving forward, the hospital will continue to leverage the advantages of the "Hong Kong-Macau Drug and Device Connect" policy, continuously enrich treatment options, and steadily enhance its capabilities in diagnosing and treating complex, severe, and rare diseases. Through more precise treatment plan

Heyou Pinnacle Medical Center is committed to a multidisciplinary approach. When needed, we assemble specialists for a comprehensive case review, delivering truly integrated, one-stop care.